chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 24.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vaccination complication
Clinical narrative: March 9th - Took vaccine April 1st - started feeling tingling sensations and numbness in both arms, and sometimes the legs April 15th - a white plaque under tongue  April 23rd - went to a doctor's office in Mexico to get blood test and a CAT scan of the brain to check neuro activity due to tingling sensations (they said nothing was found) July 7th - tested positive for COVID  July 15th - tingling sensation and numbness started again, even worse August 25th - flew to see the best neurologist in town  August 29th - discovered I was suffering from a viral inflammation that attacked my nervous system, caused by vaccines (ADEM) September 1st - started my treatment with corticosteroids for 5 consecutive days by IV injections September 5th - last day of treatment  October 1st - no signs of betterment, started another treatment with corticosteroids
Age: 24.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acute disseminated encephalomyelitis, Agitation, COVID-19, Central nervous system inflammation, Hypoaesthesia
Clinical narrative: March 9th - Took vaccine April 1st - started feeling tingling sensations and numbness in both arms, and sometimes the legs April 15th - a white plaque under tongue  April 23rd - went to a doctor's office in Mexico to get blood test and a CAT scan of the brain to check neuro activity due to tingling sensations (they said nothing was found) July 7th - tested positive for COVID  July 15th - tingling sensation and numbness started again, even worse August 25th - flew to see the best neurologist in town  August 29th - discovered I was suffering from a viral inflammation that attacked my nervous system, caused by vaccines (ADEM) September 1st - started my treatment with corticosteroids for 5 consecutive days by IV injections September 5th - last day of treatment  October 1st - no signs of betterment, started another treatment with corticosteroids
Age: 24.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Limb discomfort, Noninfective encephalitis, Oropharyngeal plaque, Pain in extremity, Paraesthesia
Clinical narrative: March 9th - Took vaccine April 1st - started feeling tingling sensations and numbness in both arms, and sometimes the legs April 15th - a white plaque under tongue  April 23rd - went to a doctor's office in Mexico to get blood test and a CAT scan of the brain to check neuro activity due to tingling sensations (they said nothing was found) July 7th - tested positive for COVID  July 15th - tingling sensation and numbness started again, even worse August 25th - flew to see the best neurologist in town  August 29th - discovered I was suffering from a viral inflammation that attacked my nervous system, caused by vaccines (ADEM) September 1st - started my treatment with corticosteroids for 5 consecutive days by IV injections September 5th - last day of treatment  October 1st - no signs of betterment, started another treatment with corticosteroids
Age: 24.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Raynaud's phenomenon, Vaccination complication, Vaccination failure
Clinical narrative: March 9th - Took vaccine April 1st - started feeling tingling sensations and numbness in both arms, and sometimes the legs April 15th - a white plaque under tongue  April 23rd - went to a doctor's office in Mexico to get blood test and a CAT scan of the brain to check neuro activity due to tingling sensations (they said nothing was found) July 7th - tested positive for COVID  July 15th - tingling sensation and numbness started again, even worse August 25th - flew to see the best neurologist in town  August 29th - discovered I was suffering from a viral inflammation that attacked my nervous system, caused by vaccines (ADEM) September 1st - started my treatment with corticosteroids for 5 consecutive days by IV injections September 5th - last day of treatment  October 1st - no signs of betterment, started another treatment with corticosteroids
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Pain, Pain in extremity, Urticaria
Clinical narrative: Arm all the way up to neck was very sore for the first 2 days. This evening I noticed 3 welts about 4? away from the injection site that are painful to touch and have no other explainable cause..
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram normal, Hepatic pain
Clinical narrative: My right side where my liver is was so sore I could not touch my whole side. I was in severe pain.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Ear discomfort
Clinical narrative: Pressure in ears, like after being on a plane
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiomyopathy, Chest pain, Chills, Echocardiogram abnormal, Ejection fraction decreased
Clinical narrative: I had the pfizer vaccine dose 1 on 18/21 and second dose 1/27/21. I had covid Dec 2 2020.  my covid symptoms werevery  mild.  I had anosmia for 2 days.  I had a fever of 101.5 on Dec 5 2020. I ran on the treadmill and lifted weights every day while on my covid quarantine.    Shortly after the first dose (4-6 hours) of my pfizer vaccine I had body aches, chills, and severe fatigue. this lasted two days.  4-5 hours after my second dose on 1/27/21 I had similar symptoms,  I did have chest pain that I believed to be acid reflux and was seen by a cardiologist in late April because my father has a congenital heart issue and wanted to be sure my chest pain was not cardiac in nature.  I did have an echo 4/27/21 which showed of 40-50% with global hypokinesis. The cardiologist diagnosed me with cardiomyopathy. Then cardiac MRI 5/5/21 which showed EF 49% with global hypokinesis. I then had a stress echo on 8/12/21 which showed resolution , normal wall motion and resting EF of 55-60%.  My cardiologist told me that my cardiomyopathy was possibly from covid. My concern is that my most significant symptoms and fatigue were only after the vaccine.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Hypokinesia, Magnetic resonance imaging abnormal, Magnetic resonance imaging heart, Pain
Clinical narrative: I had the pfizer vaccine dose 1 on 18/21 and second dose 1/27/21. I had covid Dec 2 2020.  my covid symptoms werevery  mild.  I had anosmia for 2 days.  I had a fever of 101.5 on Dec 5 2020. I ran on the treadmill and lifted weights every day while on my covid quarantine.    Shortly after the first dose (4-6 hours) of my pfizer vaccine I had body aches, chills, and severe fatigue. this lasted two days.  4-5 hours after my second dose on 1/27/21 I had similar symptoms,  I did have chest pain that I believed to be acid reflux and was seen by a cardiologist in late April because my father has a congenital heart issue and wanted to be sure my chest pain was not cardiac in nature.  I did have an echo 4/27/21 which showed of 40-50% with global hypokinesis. The cardiologist diagnosed me with cardiomyopathy. Then cardiac MRI 5/5/21 which showed EF 49% with global hypokinesis. I then had a stress echo on 8/12/21 which showed resolution , normal wall motion and resting EF of 55-60%.  My cardiologist told me that my cardiomyopathy was possibly from covid. My concern is that my most significant symptoms and fatigue were only after the vaccine.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Stress echocardiogram
Clinical narrative: I had the pfizer vaccine dose 1 on 18/21 and second dose 1/27/21. I had covid Dec 2 2020.  my covid symptoms werevery  mild.  I had anosmia for 2 days.  I had a fever of 101.5 on Dec 5 2020. I ran on the treadmill and lifted weights every day while on my covid quarantine.    Shortly after the first dose (4-6 hours) of my pfizer vaccine I had body aches, chills, and severe fatigue. this lasted two days.  4-5 hours after my second dose on 1/27/21 I had similar symptoms,  I did have chest pain that I believed to be acid reflux and was seen by a cardiologist in late April because my father has a congenital heart issue and wanted to be sure my chest pain was not cardiac in nature.  I did have an echo 4/27/21 which showed of 40-50% with global hypokinesis. The cardiologist diagnosed me with cardiomyopathy. Then cardiac MRI 5/5/21 which showed EF 49% with global hypokinesis. I then had a stress echo on 8/12/21 which showed resolution , normal wall motion and resting EF of 55-60%.  My cardiologist told me that my cardiomyopathy was possibly from covid. My concern is that my most significant symptoms and fatigue were only after the vaccine.
Age: 67.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site bruising, Injection site discolouration, Injection site swelling, Product administered at inappropriate site
Clinical narrative: Pt came into pharmacy. Complaint about  severe bruising and swelling on injection site persisting 1 week after immunization. Right arm was large area of  bruising and yellowish color. Injection site may have been too low (under deltoid for IM). Suggested patient check with MD if bruising persists.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: Erythema at injection site, warmth. Starting 10/01/2021 Tx prednisone, Benadryl & Pepcid
Age: 62.0
Sex: F
Vaccine: FLU4
Symptoms: Dizziness, Hyperhidrosis, Injection site bruising, Injection site pain, Nausea
Clinical narrative: - Bruising and pain at injection site  - After returning home , pt reported  feeling  lightheaded, sweats , and nauseous.  These symptoms  have impaired slightly , but still remain.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Axillary pain, Chest pain, Oedema peripheral, Pain, Swelling
Clinical narrative: Initially patient claims entire body was sore and swollen on 10/1/21. Then on 10/2/21 only under his arm/chest was still sore and swollen.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered, Interchange of vaccine products, Pain in extremity, Wrong product administered
Clinical narrative: PATIENT INTENDED TO GET THE FLUZONE HD BUT INSTEAD RECEIVED COVID19/PFIZER VACCINE PATIENT HAD ALREADY RECEIVED BOTH DOSES OF COVID19/MODERNA VACCINE IN JANUARY AND FEBRUARY. PATIENT ONLY REPORTED ARM PAIN
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Dysstasia, Fatigue, Gait disturbance, Muscular weakness, Musculoskeletal disorder
Clinical narrative: Extremities became very weak  Received Pfizer covid vaccine in March and April of 2021. With a couple of weeks, Both legs became weak affecting standing and walking. Right hand became very weak affecting the dexterity of fingers and not being able to use it for anything. Both arms were weak. Became very tired since the vaccine. Muscle strength has improved some but not like it was. Still having trouble with left arm,
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Oral mucosal blistering, Oropharyngeal pain, SARS-CoV-2 test negative
Clinical narrative: Shortly after Pfizer Covid-19 vaccine I developed blisters in my mouth - after second vaccine I got a persistent sore throat and more blisters. Evaluation by dentist and several doctors with no resolution
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Haemophagocytic lymphohistiocytosis, Platelet count decreased
Clinical narrative: Patient received Pfizer COVID vaccine and then developed possible Hemophagocytic lymphohistiocytosis.
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Hypertension
Clinical narrative: I had a dr appointment 2 hrs after the 1st dose of Pfizer, my blood pressure was 195/95. It is usually 155/85. It stayed high for a couple weeks. I took extra potassium and cut out all caffeine to help bring it down. It happened again with the 2nd dose on 4/22/21. Taken at my Urologist
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Eye pruritus, Gastrointestinal disorder, Hypersensitivity, Hypoaesthesia, Hypoaesthesia oral
Clinical narrative: Received Pfizer Covid 19 vaccine on October 2nd, 2021 around 5:30pm. By next morning had facial/lip swelling and numbness. Itchy skin around lips, itchy ears, itchy/watery eyes, runny nose and gastrointestinal symptoms. Went to Dr same morning and diagnosed with allergic reaction.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Lacrimation increased, Lip swelling, Pruritus, Rhinorrhoea, Swelling face
Clinical narrative: Received Pfizer Covid 19 vaccine on October 2nd, 2021 around 5:30pm. By next morning had facial/lip swelling and numbness. Itchy skin around lips, itchy ears, itchy/watery eyes, runny nose and gastrointestinal symptoms. Went to Dr same morning and diagnosed with allergic reaction.
Sex: M
Vaccine: COVID19
Symptoms: Eye disorder, Psoriasis
Clinical narrative: afterl I received second MODERNA Covid 19 vaccine on March 9,2021 I have developed very bad psoriasis on my legs and mid section of my body..... I also developed EYE problems..... Should I receive a booster when available?????
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Breath sounds abnormal, Dyspnoea, Obstructive airways disorder, Respiratory tract congestion
Clinical narrative: Patient developed severe congestion and trouble breathing. Air way felt restricted, rattling slung sounds 30 days after second dose of Pfizer COVID-19 Vaccine.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Conversion disorder, Dysphagia, Gait disturbance, Imaging procedure
Clinical narrative: Had severe functional neurologic disorder 6 weeks after the second dose of Pfizer vaccination. It went away after several months. Just had a booster shot yesterday and I have the same symptoms again. Freezing gait. Difficulty swallowing. The symptoms are severe. The first episode I didn't know what it was. I was hospitalized for several days and doctors thought I had Parkinson's or Progressive Supranuclear Palsy. But after a tertiary neurological consult I was diagnosed with functional gait disorder. Symptoms got better after a month or so and taking Lexapro. I had the booster shot yesterday and today the symptoms have returned. Freezing gait and anxiety. It just started but is clearly from the vaccination. I read of other reports of functional neurological disorders following the vaccination. MRI and all radiology studies were normal. Hopefully this will go away as it did the first time. It's terrible.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Magnetic resonance imaging normal
Clinical narrative: Had severe functional neurologic disorder 6 weeks after the second dose of Pfizer vaccination. It went away after several months. Just had a booster shot yesterday and I have the same symptoms again. Freezing gait. Difficulty swallowing. The symptoms are severe. The first episode I didn't know what it was. I was hospitalized for several days and doctors thought I had Parkinson's or Progressive Supranuclear Palsy. But after a tertiary neurological consult I was diagnosed with functional gait disorder. Symptoms got better after a month or so and taking Lexapro. I had the booster shot yesterday and today the symptoms have returned. Freezing gait and anxiety. It just started but is clearly from the vaccination. I read of other reports of functional neurological disorders following the vaccination. MRI and all radiology studies were normal. Hopefully this will go away as it did the first time. It's terrible.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Headache, Pruritus, Pyrexia
Clinical narrative: Patient contracted COVID after being fully vaccinated runny nose and congestion
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Nasal congestion, Rhinorrhoea
Clinical narrative: Patient contracted COVID after being fully vaccinated runny nose and congestion
Age: 18.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Alanine aminotransferase increased, Angiogram pulmonary normal, Arthralgia, Aspartate aminotransferase increased, Autoimmune disorder
Clinical narrative: Myopericarditis.  Hospitalized for 24 hours.  Elevated troponin.  Treated with colchicine.  Symptoms improved with treatment.
Age: 18.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Brain natriuretic peptide increased, C-reactive protein increased, Cardiac telemetry, Chest pain, Electrocardiogram T wave inversion
Clinical narrative: Myopericarditis.  Hospitalized for 24 hours.  Elevated troponin.  Treated with colchicine.  Symptoms improved with treatment.
Age: 18.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram abnormal, Fibrin D dimer increased, Full blood count normal, Liver function test abnormal, Metabolic function test normal
Clinical narrative: Myopericarditis.  Hospitalized for 24 hours.  Elevated troponin.  Treated with colchicine.  Symptoms improved with treatment.
Age: 18.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Myocarditis, Pain, Painful respiration, Pericarditis, Pleuritic pain
Clinical narrative: Myopericarditis.  Hospitalized for 24 hours.  Elevated troponin.  Treated with colchicine.  Symptoms improved with treatment.
Age: 18.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Red blood cell sedimentation rate normal, Systemic immune activation, Troponin I increased, Vaccination complication, Vomiting
Clinical narrative: Myopericarditis.  Hospitalized for 24 hours.  Elevated troponin.  Treated with colchicine.  Symptoms improved with treatment.
Age: 18.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Echocardiogram, Myocarditis, Troponin increased
Clinical narrative: Myopericarditis.  Hospitalized for 24 hours.  Elevated troponin.  Treated with colchicine.  Symptoms improved with treatment.
Age: 50.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Facial nerve disorder, Hypoaesthesia, Hypoaesthesia oral, Lymphadenopathy, Magnetic resonance imaging head abnormal
Clinical narrative: Five days after receiving a 3rd dose of Pfizer?s COVID vaccine, patient experienced painful bilateral musculoskeletal back spasms that progressively ascended from the lumbar to cervical region over the course of 4 days.  Previously, he was in his usual state of health with no recent history of infection, rash, travel abroad, exposure to tick bites or trauma.  Patient is a non-smoker and does not consume alcohol/illicit drugs.  First Pfizer Vaccine Dose on 16 Feb 2021 and Second Pfizer Dose on 9 March 2021 with minimal side effects for 36 hours.   By Day 4, various back regions began losing sensation in thoracic dermatomes, with onset of bilateral finger tip tingling (median nerve distribution - 1st thru 3rd digits), altered taste sensation, bilateral facial pain and bilateral dorsal foot and toe numbness.  On Day 5, there was onset of prominent fatigue, oral/buccal numbness, complete loss of taste and rapidly progressive right facial paresis to paralysis within 12 hours.  This prompted an ER visit, with a negative head CT.  By Day 6, there was severe right facial paralysis with left facial paresis and loss of ability to hold water or food in mouth with impaired speech.   Admitted to inpatient neurology on Day 7 of symptom onset (Day 11 after vaccine administration) with bilateral reduced patellar and absent ankle reflexes, lower extremity muscle weakness progression, episodic vertigo with nausea/vomiting and diffuse extremity/back paresthesia or numbness.  On Day 8, there was bilateral complete loss of patellar and ankle reflexes and R > L 4/5 proximal leg weakness.  Preserved upper extremity reflexes and afebrile throughout hospitalization.  Loss of pinprick to mid-calf bilaterally.  Mastication fatigue without dysphagia.  Pulmonary function assessments were within normal limits.  No bladder or bowel involvement at any point.  Lumbar puncture with albumin-cytological dissocation.  Diagnosed with Acute Inflammatory Demyelinating Polyneuropathy (Guillain-Barre Syndrome) due to COVID vaccination.  Treated with IVIG over a 5 day period with hypertension elevations.   Symptom plateau half-way through treatment.  Discharge home on hospital day #8 with ability to ambulate short-distance without assistive devices, but with easy muscular fatigue.
Age: 50.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Myalgia, Paraesthesia
Clinical narrative: Five days after receiving a 3rd dose of Pfizer?s COVID vaccine, patient experienced painful bilateral musculoskeletal back spasms that progressively ascended from the lumbar to cervical region over the course of 4 days.  Previously, he was in his usual state of health with no recent history of infection, rash, travel abroad, exposure to tick bites or trauma.  Patient is a non-smoker and does not consume alcohol/illicit drugs.  First Pfizer Vaccine Dose on 16 Feb 2021 and Second Pfizer Dose on 9 March 2021 with minimal side effects for 36 hours.   By Day 4, various back regions began losing sensation in thoracic dermatomes, with onset of bilateral finger tip tingling (median nerve distribution - 1st thru 3rd digits), altered taste sensation, bilateral facial pain and bilateral dorsal foot and toe numbness.  On Day 5, there was onset of prominent fatigue, oral/buccal numbness, complete loss of taste and rapidly progressive right facial paresis to paralysis within 12 hours.  This prompted an ER visit, with a negative head CT.  By Day 6, there was severe right facial paralysis with left facial paresis and loss of ability to hold water or food in mouth with impaired speech.   Admitted to inpatient neurology on Day 7 of symptom onset (Day 11 after vaccine administration) with bilateral reduced patellar and absent ankle reflexes, lower extremity muscle weakness progression, episodic vertigo with nausea/vomiting and diffuse extremity/back paresthesia or numbness.  On Day 8, there was bilateral complete loss of patellar and ankle reflexes and R > L 4/5 proximal leg weakness.  Preserved upper extremity reflexes and afebrile throughout hospitalization.  Loss of pinprick to mid-calf bilaterally.  Mastication fatigue without dysphagia.  Pulmonary function assessments were within normal limits.  No bladder or bowel involvement at any point.  Lumbar puncture with albumin-cytological dissocation.  Diagnosed with Acute Inflammatory Demyelinating Polyneuropathy (Guillain-Barre Syndrome) due to COVID vaccination.  Treated with IVIG over a 5 day period with hypertension elevations.   Symptom plateau half-way through treatment.  Discharge home on hospital day #8 with ability to ambulate short-distance without assistive devices, but with easy muscular fatigue.
Age: 50.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Areflexia, Facial paresis, Guillain-Barre syndrome, Immunoglobulin therapy, Magnetic resonance imaging head
Clinical narrative: Five days after receiving a 3rd dose of Pfizer?s COVID vaccine, patient experienced painful bilateral musculoskeletal back spasms that progressively ascended from the lumbar to cervical region over the course of 4 days.  Previously, he was in his usual state of health with no recent history of infection, rash, travel abroad, exposure to tick bites or trauma.  Patient is a non-smoker and does not consume alcohol/illicit drugs.  First Pfizer Vaccine Dose on 16 Feb 2021 and Second Pfizer Dose on 9 March 2021 with minimal side effects for 36 hours.   By Day 4, various back regions began losing sensation in thoracic dermatomes, with onset of bilateral finger tip tingling (median nerve distribution - 1st thru 3rd digits), altered taste sensation, bilateral facial pain and bilateral dorsal foot and toe numbness.  On Day 5, there was onset of prominent fatigue, oral/buccal numbness, complete loss of taste and rapidly progressive right facial paresis to paralysis within 12 hours.  This prompted an ER visit, with a negative head CT.  By Day 6, there was severe right facial paralysis with left facial paresis and loss of ability to hold water or food in mouth with impaired speech.   Admitted to inpatient neurology on Day 7 of symptom onset (Day 11 after vaccine administration) with bilateral reduced patellar and absent ankle reflexes, lower extremity muscle weakness progression, episodic vertigo with nausea/vomiting and diffuse extremity/back paresthesia or numbness.  On Day 8, there was bilateral complete loss of patellar and ankle reflexes and R > L 4/5 proximal leg weakness.  Preserved upper extremity reflexes and afebrile throughout hospitalization.  Loss of pinprick to mid-calf bilaterally.  Mastication fatigue without dysphagia.  Pulmonary function assessments were within normal limits.  No bladder or bowel involvement at any point.  Lumbar puncture with albumin-cytological dissocation.  Diagnosed with Acute Inflammatory Demyelinating Polyneuropathy (Guillain-Barre Syndrome) due to COVID vaccination.  Treated with IVIG over a 5 day period with hypertension elevations.   Symptom plateau half-way through treatment.  Discharge home on hospital day #8 with ability to ambulate short-distance without assistive devices, but with easy muscular fatigue.
Age: 50.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Mobility decreased, Muscular weakness, Paraesthesia
Clinical narrative: Five days after receiving a 3rd dose of Pfizer?s COVID vaccine, patient experienced painful bilateral musculoskeletal back spasms that progressively ascended from the lumbar to cervical region over the course of 4 days.  Previously, he was in his usual state of health with no recent history of infection, rash, travel abroad, exposure to tick bites or trauma.  Patient is a non-smoker and does not consume alcohol/illicit drugs.  First Pfizer Vaccine Dose on 16 Feb 2021 and Second Pfizer Dose on 9 March 2021 with minimal side effects for 36 hours.   By Day 4, various back regions began losing sensation in thoracic dermatomes, with onset of bilateral finger tip tingling (median nerve distribution - 1st thru 3rd digits), altered taste sensation, bilateral facial pain and bilateral dorsal foot and toe numbness.  On Day 5, there was onset of prominent fatigue, oral/buccal numbness, complete loss of taste and rapidly progressive right facial paresis to paralysis within 12 hours.  This prompted an ER visit, with a negative head CT.  By Day 6, there was severe right facial paralysis with left facial paresis and loss of ability to hold water or food in mouth with impaired speech.   Admitted to inpatient neurology on Day 7 of symptom onset (Day 11 after vaccine administration) with bilateral reduced patellar and absent ankle reflexes, lower extremity muscle weakness progression, episodic vertigo with nausea/vomiting and diffuse extremity/back paresthesia or numbness.  On Day 8, there was bilateral complete loss of patellar and ankle reflexes and R > L 4/5 proximal leg weakness.  Preserved upper extremity reflexes and afebrile throughout hospitalization.  Loss of pinprick to mid-calf bilaterally.  Mastication fatigue without dysphagia.  Pulmonary function assessments were within normal limits.  No bladder or bowel involvement at any point.  Lumbar puncture with albumin-cytological dissocation.  Diagnosed with Acute Inflammatory Demyelinating Polyneuropathy (Guillain-Barre Syndrome) due to COVID vaccination.  Treated with IVIG over a 5 day period with hypertension elevations.   Symptom plateau half-way through treatment.  Discharge home on hospital day #8 with ability to ambulate short-distance without assistive devices, but with easy muscular fatigue.
Age: 50.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abstains from alcohol, Ageusia, Areflexia, Blood glucose normal, Bordetella test negative
Clinical narrative: Five days after receiving a 3rd dose of Pfizer?s COVID vaccine, patient experienced painful bilateral musculoskeletal back spasms that progressively ascended from the lumbar to cervical region over the course of 4 days.  Previously, he was in his usual state of health with no recent history of infection, rash, travel abroad, exposure to tick bites or trauma.  Patient is a non-smoker and does not consume alcohol/illicit drugs.  First Pfizer Vaccine Dose on 16 Feb 2021 and Second Pfizer Dose on 9 March 2021 with minimal side effects for 36 hours.   By Day 4, various back regions began losing sensation in thoracic dermatomes, with onset of bilateral finger tip tingling (median nerve distribution - 1st thru 3rd digits), altered taste sensation, bilateral facial pain and bilateral dorsal foot and toe numbness.  On Day 5, there was onset of prominent fatigue, oral/buccal numbness, complete loss of taste and rapidly progressive right facial paresis to paralysis within 12 hours.  This prompted an ER visit, with a negative head CT.  By Day 6, there was severe right facial paralysis with left facial paresis and loss of ability to hold water or food in mouth with impaired speech.   Admitted to inpatient neurology on Day 7 of symptom onset (Day 11 after vaccine administration) with bilateral reduced patellar and absent ankle reflexes, lower extremity muscle weakness progression, episodic vertigo with nausea/vomiting and diffuse extremity/back paresthesia or numbness.  On Day 8, there was bilateral complete loss of patellar and ankle reflexes and R > L 4/5 proximal leg weakness.  Preserved upper extremity reflexes and afebrile throughout hospitalization.  Loss of pinprick to mid-calf bilaterally.  Mastication fatigue without dysphagia.  Pulmonary function assessments were within normal limits.  No bladder or bowel involvement at any point.  Lumbar puncture with albumin-cytological dissocation.  Diagnosed with Acute Inflammatory Demyelinating Polyneuropathy (Guillain-Barre Syndrome) due to COVID vaccination.  Treated with IVIG over a 5 day period with hypertension elevations.   Symptom plateau half-way through treatment.  Discharge home on hospital day #8 with ability to ambulate short-distance without assistive devices, but with easy muscular fatigue.
Age: 50.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: C-reactive protein increased, CSF culture negative, CSF glucose increased, CSF oligoclonal band absent, CSF protein increased
Clinical narrative: Five days after receiving a 3rd dose of Pfizer?s COVID vaccine, patient experienced painful bilateral musculoskeletal back spasms that progressively ascended from the lumbar to cervical region over the course of 4 days.  Previously, he was in his usual state of health with no recent history of infection, rash, travel abroad, exposure to tick bites or trauma.  Patient is a non-smoker and does not consume alcohol/illicit drugs.  First Pfizer Vaccine Dose on 16 Feb 2021 and Second Pfizer Dose on 9 March 2021 with minimal side effects for 36 hours.   By Day 4, various back regions began losing sensation in thoracic dermatomes, with onset of bilateral finger tip tingling (median nerve distribution - 1st thru 3rd digits), altered taste sensation, bilateral facial pain and bilateral dorsal foot and toe numbness.  On Day 5, there was onset of prominent fatigue, oral/buccal numbness, complete loss of taste and rapidly progressive right facial paresis to paralysis within 12 hours.  This prompted an ER visit, with a negative head CT.  By Day 6, there was severe right facial paralysis with left facial paresis and loss of ability to hold water or food in mouth with impaired speech.   Admitted to inpatient neurology on Day 7 of symptom onset (Day 11 after vaccine administration) with bilateral reduced patellar and absent ankle reflexes, lower extremity muscle weakness progression, episodic vertigo with nausea/vomiting and diffuse extremity/back paresthesia or numbness.  On Day 8, there was bilateral complete loss of patellar and ankle reflexes and R > L 4/5 proximal leg weakness.  Preserved upper extremity reflexes and afebrile throughout hospitalization.  Loss of pinprick to mid-calf bilaterally.  Mastication fatigue without dysphagia.  Pulmonary function assessments were within normal limits.  No bladder or bowel involvement at any point.  Lumbar puncture with albumin-cytological dissocation.  Diagnosed with Acute Inflammatory Demyelinating Polyneuropathy (Guillain-Barre Syndrome) due to COVID vaccination.  Treated with IVIG over a 5 day period with hypertension elevations.   Symptom plateau half-way through treatment.  Discharge home on hospital day #8 with ability to ambulate short-distance without assistive devices, but with easy muscular fatigue.
Age: 50.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: CSF white blood cell count negative, Computerised tomogram abdomen, Computerised tomogram head normal, Computerised tomogram thorax abnormal, Condition aggravated
Clinical narrative: Five days after receiving a 3rd dose of Pfizer?s COVID vaccine, patient experienced painful bilateral musculoskeletal back spasms that progressively ascended from the lumbar to cervical region over the course of 4 days.  Previously, he was in his usual state of health with no recent history of infection, rash, travel abroad, exposure to tick bites or trauma.  Patient is a non-smoker and does not consume alcohol/illicit drugs.  First Pfizer Vaccine Dose on 16 Feb 2021 and Second Pfizer Dose on 9 March 2021 with minimal side effects for 36 hours.   By Day 4, various back regions began losing sensation in thoracic dermatomes, with onset of bilateral finger tip tingling (median nerve distribution - 1st thru 3rd digits), altered taste sensation, bilateral facial pain and bilateral dorsal foot and toe numbness.  On Day 5, there was onset of prominent fatigue, oral/buccal numbness, complete loss of taste and rapidly progressive right facial paresis to paralysis within 12 hours.  This prompted an ER visit, with a negative head CT.  By Day 6, there was severe right facial paralysis with left facial paresis and loss of ability to hold water or food in mouth with impaired speech.   Admitted to inpatient neurology on Day 7 of symptom onset (Day 11 after vaccine administration) with bilateral reduced patellar and absent ankle reflexes, lower extremity muscle weakness progression, episodic vertigo with nausea/vomiting and diffuse extremity/back paresthesia or numbness.  On Day 8, there was bilateral complete loss of patellar and ankle reflexes and R > L 4/5 proximal leg weakness.  Preserved upper extremity reflexes and afebrile throughout hospitalization.  Loss of pinprick to mid-calf bilaterally.  Mastication fatigue without dysphagia.  Pulmonary function assessments were within normal limits.  No bladder or bowel involvement at any point.  Lumbar puncture with albumin-cytological dissocation.  Diagnosed with Acute Inflammatory Demyelinating Polyneuropathy (Guillain-Barre Syndrome) due to COVID vaccination.  Treated with IVIG over a 5 day period with hypertension elevations.   Symptom plateau half-way through treatment.  Discharge home on hospital day #8 with ability to ambulate short-distance without assistive devices, but with easy muscular fatigue.
Age: 50.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cryptococcus test, Facial pain, Facial paralysis, Facial paresis, Fatigue
Clinical narrative: Five days after receiving a 3rd dose of Pfizer?s COVID vaccine, patient experienced painful bilateral musculoskeletal back spasms that progressively ascended from the lumbar to cervical region over the course of 4 days.  Previously, he was in his usual state of health with no recent history of infection, rash, travel abroad, exposure to tick bites or trauma.  Patient is a non-smoker and does not consume alcohol/illicit drugs.  First Pfizer Vaccine Dose on 16 Feb 2021 and Second Pfizer Dose on 9 March 2021 with minimal side effects for 36 hours.   By Day 4, various back regions began losing sensation in thoracic dermatomes, with onset of bilateral finger tip tingling (median nerve distribution - 1st thru 3rd digits), altered taste sensation, bilateral facial pain and bilateral dorsal foot and toe numbness.  On Day 5, there was onset of prominent fatigue, oral/buccal numbness, complete loss of taste and rapidly progressive right facial paresis to paralysis within 12 hours.  This prompted an ER visit, with a negative head CT.  By Day 6, there was severe right facial paralysis with left facial paresis and loss of ability to hold water or food in mouth with impaired speech.   Admitted to inpatient neurology on Day 7 of symptom onset (Day 11 after vaccine administration) with bilateral reduced patellar and absent ankle reflexes, lower extremity muscle weakness progression, episodic vertigo with nausea/vomiting and diffuse extremity/back paresthesia or numbness.  On Day 8, there was bilateral complete loss of patellar and ankle reflexes and R > L 4/5 proximal leg weakness.  Preserved upper extremity reflexes and afebrile throughout hospitalization.  Loss of pinprick to mid-calf bilaterally.  Mastication fatigue without dysphagia.  Pulmonary function assessments were within normal limits.  No bladder or bowel involvement at any point.  Lumbar puncture with albumin-cytological dissocation.  Diagnosed with Acute Inflammatory Demyelinating Polyneuropathy (Guillain-Barre Syndrome) due to COVID vaccination.  Treated with IVIG over a 5 day period with hypertension elevations.   Symptom plateau half-way through treatment.  Discharge home on hospital day #8 with ability to ambulate short-distance without assistive devices, but with easy muscular fatigue.
Age: 50.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Flow cytometry, Full blood count, Guillain-Barre syndrome, Hypertension, Hypoaesthesia
Clinical narrative: Five days after receiving a 3rd dose of Pfizer?s COVID vaccine, patient experienced painful bilateral musculoskeletal back spasms that progressively ascended from the lumbar to cervical region over the course of 4 days.  Previously, he was in his usual state of health with no recent history of infection, rash, travel abroad, exposure to tick bites or trauma.  Patient is a non-smoker and does not consume alcohol/illicit drugs.  First Pfizer Vaccine Dose on 16 Feb 2021 and Second Pfizer Dose on 9 March 2021 with minimal side effects for 36 hours.   By Day 4, various back regions began losing sensation in thoracic dermatomes, with onset of bilateral finger tip tingling (median nerve distribution - 1st thru 3rd digits), altered taste sensation, bilateral facial pain and bilateral dorsal foot and toe numbness.  On Day 5, there was onset of prominent fatigue, oral/buccal numbness, complete loss of taste and rapidly progressive right facial paresis to paralysis within 12 hours.  This prompted an ER visit, with a negative head CT.  By Day 6, there was severe right facial paralysis with left facial paresis and loss of ability to hold water or food in mouth with impaired speech.   Admitted to inpatient neurology on Day 7 of symptom onset (Day 11 after vaccine administration) with bilateral reduced patellar and absent ankle reflexes, lower extremity muscle weakness progression, episodic vertigo with nausea/vomiting and diffuse extremity/back paresthesia or numbness.  On Day 8, there was bilateral complete loss of patellar and ankle reflexes and R > L 4/5 proximal leg weakness.  Preserved upper extremity reflexes and afebrile throughout hospitalization.  Loss of pinprick to mid-calf bilaterally.  Mastication fatigue without dysphagia.  Pulmonary function assessments were within normal limits.  No bladder or bowel involvement at any point.  Lumbar puncture with albumin-cytological dissocation.  Diagnosed with Acute Inflammatory Demyelinating Polyneuropathy (Guillain-Barre Syndrome) due to COVID vaccination.  Treated with IVIG over a 5 day period with hypertension elevations.   Symptom plateau half-way through treatment.  Discharge home on hospital day #8 with ability to ambulate short-distance without assistive devices, but with easy muscular fatigue.
Age: 50.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hypoaesthesia oral, Hyporeflexia, Immunoglobulin therapy, Lumbar puncture, Magnetic resonance imaging head abnormal
Clinical narrative: Five days after receiving a 3rd dose of Pfizer?s COVID vaccine, patient experienced painful bilateral musculoskeletal back spasms that progressively ascended from the lumbar to cervical region over the course of 4 days.  Previously, he was in his usual state of health with no recent history of infection, rash, travel abroad, exposure to tick bites or trauma.  Patient is a non-smoker and does not consume alcohol/illicit drugs.  First Pfizer Vaccine Dose on 16 Feb 2021 and Second Pfizer Dose on 9 March 2021 with minimal side effects for 36 hours.   By Day 4, various back regions began losing sensation in thoracic dermatomes, with onset of bilateral finger tip tingling (median nerve distribution - 1st thru 3rd digits), altered taste sensation, bilateral facial pain and bilateral dorsal foot and toe numbness.  On Day 5, there was onset of prominent fatigue, oral/buccal numbness, complete loss of taste and rapidly progressive right facial paresis to paralysis within 12 hours.  This prompted an ER visit, with a negative head CT.  By Day 6, there was severe right facial paralysis with left facial paresis and loss of ability to hold water or food in mouth with impaired speech.   Admitted to inpatient neurology on Day 7 of symptom onset (Day 11 after vaccine administration) with bilateral reduced patellar and absent ankle reflexes, lower extremity muscle weakness progression, episodic vertigo with nausea/vomiting and diffuse extremity/back paresthesia or numbness.  On Day 8, there was bilateral complete loss of patellar and ankle reflexes and R > L 4/5 proximal leg weakness.  Preserved upper extremity reflexes and afebrile throughout hospitalization.  Loss of pinprick to mid-calf bilaterally.  Mastication fatigue without dysphagia.  Pulmonary function assessments were within normal limits.  No bladder or bowel involvement at any point.  Lumbar puncture with albumin-cytological dissocation.  Diagnosed with Acute Inflammatory Demyelinating Polyneuropathy (Guillain-Barre Syndrome) due to COVID vaccination.  Treated with IVIG over a 5 day period with hypertension elevations.   Symptom plateau half-way through treatment.  Discharge home on hospital day #8 with ability to ambulate short-distance without assistive devices, but with easy muscular fatigue.
Age: 50.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Muscle fatigue, Muscle spasms, Muscular weakness, Musculoskeletal pain, Nausea
Clinical narrative: Five days after receiving a 3rd dose of Pfizer?s COVID vaccine, patient experienced painful bilateral musculoskeletal back spasms that progressively ascended from the lumbar to cervical region over the course of 4 days.  Previously, he was in his usual state of health with no recent history of infection, rash, travel abroad, exposure to tick bites or trauma.  Patient is a non-smoker and does not consume alcohol/illicit drugs.  First Pfizer Vaccine Dose on 16 Feb 2021 and Second Pfizer Dose on 9 March 2021 with minimal side effects for 36 hours.   By Day 4, various back regions began losing sensation in thoracic dermatomes, with onset of bilateral finger tip tingling (median nerve distribution - 1st thru 3rd digits), altered taste sensation, bilateral facial pain and bilateral dorsal foot and toe numbness.  On Day 5, there was onset of prominent fatigue, oral/buccal numbness, complete loss of taste and rapidly progressive right facial paresis to paralysis within 12 hours.  This prompted an ER visit, with a negative head CT.  By Day 6, there was severe right facial paralysis with left facial paresis and loss of ability to hold water or food in mouth with impaired speech.   Admitted to inpatient neurology on Day 7 of symptom onset (Day 11 after vaccine administration) with bilateral reduced patellar and absent ankle reflexes, lower extremity muscle weakness progression, episodic vertigo with nausea/vomiting and diffuse extremity/back paresthesia or numbness.  On Day 8, there was bilateral complete loss of patellar and ankle reflexes and R > L 4/5 proximal leg weakness.  Preserved upper extremity reflexes and afebrile throughout hospitalization.  Loss of pinprick to mid-calf bilaterally.  Mastication fatigue without dysphagia.  Pulmonary function assessments were within normal limits.  No bladder or bowel involvement at any point.  Lumbar puncture with albumin-cytological dissocation.  Diagnosed with Acute Inflammatory Demyelinating Polyneuropathy (Guillain-Barre Syndrome) due to COVID vaccination.  Treated with IVIG over a 5 day period with hypertension elevations.   Symptom plateau half-way through treatment.  Discharge home on hospital day #8 with ability to ambulate short-distance without assistive devices, but with easy muscular fatigue.
Age: 50.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Non-tobacco user, Paraesthesia, Pulmonary function test normal, Pulmonary mass, Red blood cell sedimentation rate increased
Clinical narrative: Five days after receiving a 3rd dose of Pfizer?s COVID vaccine, patient experienced painful bilateral musculoskeletal back spasms that progressively ascended from the lumbar to cervical region over the course of 4 days.  Previously, he was in his usual state of health with no recent history of infection, rash, travel abroad, exposure to tick bites or trauma.  Patient is a non-smoker and does not consume alcohol/illicit drugs.  First Pfizer Vaccine Dose on 16 Feb 2021 and Second Pfizer Dose on 9 March 2021 with minimal side effects for 36 hours.   By Day 4, various back regions began losing sensation in thoracic dermatomes, with onset of bilateral finger tip tingling (median nerve distribution - 1st thru 3rd digits), altered taste sensation, bilateral facial pain and bilateral dorsal foot and toe numbness.  On Day 5, there was onset of prominent fatigue, oral/buccal numbness, complete loss of taste and rapidly progressive right facial paresis to paralysis within 12 hours.  This prompted an ER visit, with a negative head CT.  By Day 6, there was severe right facial paralysis with left facial paresis and loss of ability to hold water or food in mouth with impaired speech.   Admitted to inpatient neurology on Day 7 of symptom onset (Day 11 after vaccine administration) with bilateral reduced patellar and absent ankle reflexes, lower extremity muscle weakness progression, episodic vertigo with nausea/vomiting and diffuse extremity/back paresthesia or numbness.  On Day 8, there was bilateral complete loss of patellar and ankle reflexes and R > L 4/5 proximal leg weakness.  Preserved upper extremity reflexes and afebrile throughout hospitalization.  Loss of pinprick to mid-calf bilaterally.  Mastication fatigue without dysphagia.  Pulmonary function assessments were within normal limits.  No bladder or bowel involvement at any point.  Lumbar puncture with albumin-cytological dissocation.  Diagnosed with Acute Inflammatory Demyelinating Polyneuropathy (Guillain-Barre Syndrome) due to COVID vaccination.  Treated with IVIG over a 5 day period with hypertension elevations.   Symptom plateau half-way through treatment.  Discharge home on hospital day #8 with ability to ambulate short-distance without assistive devices, but with easy muscular fatigue.